Plain-English translation of NCT07100600 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new breast cancer medication called in women whose HER2-positive advanced breast cancer has spread to the brain. Half of the participants will receive this medication alone, while the other half will receive it combined with radiation therapy. The goal is to see which approach works better at controlling the cancer in the brain.
Brain metastases from breast cancer are difficult to treat and can seriously affect quality of life. Researchers want to know whether combining this newer medication with radiation therapy can improve outcomes compared to using the medication by itself.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new medication alone or the medication combined with radiation therapy. You will continue treatment until your cancer progresses, you experience side effects you cannot tolerate, or the researchers decide to stop the study. Throughout the trial, you will have regular visits to monitor how you are responding to treatment and check for any side effects.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China